Gender differences in skin: A review of the literature

Gender Medicine

Volumn 4, Issue 4, 2007, Pages 308-328

  Dao Jr , Harry ^a   Kazin, Rebecca A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

gender differences; immunology and autoimmune diseases; sex steroids; skin; skin cancer; wound healing

Indexed keywords

ANDROGEN; ANTIBIOTIC AGENT; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HY ANTIGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE;

ACNE; AGING; ARTICLE; AUTOIMMUNE DISEASE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ECZEMA; ERYTHEMA CHRONICUM MIGRANS; GRAFT REJECTION; HAIR LOSS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; LANGERHANS CELL; LYME DISEASE; MALE TYPE ALOPECIA; MEDLINE; MELANOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCLERODERMA; SEBACEOUS GLAND; SEX DIFFERENCE; SKIN CANCER; SKIN DISEASE; SKIN GRAFT; SKINFOLD THICKNESS; SYSTEMIC LUPUS ERYTHEMATOSUS; WOUND HEALING;

ACNE VULGARIS; ALOPECIA; ANIMALS; AUTOIMMUNE DISEASES; FEMALE; GONADAL STEROID HORMONES; HAIR; HUMANS; MALE; SEX CHARACTERISTICS; SKIN; SKIN NEOPLASMS; WOUND HEALING;

EID: 38349001144     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(07)80061-1     Document Type: Article

References (202)

1. Holm E., Esmann S., and Jemec G. Does visible atopic dermatitis affect quality of life more in women than in men?. Gend Med 1 (2004) 125-130
2. Azzi L., El-Alfy M., Martel C., and Labrie F. Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone. J Invest Dermatol 124 (2005) 22-27
3. Moverare S., Lindberg M., Faergemann J., et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of epidermis in male mice. J Invest Dermatol 119 (2002) 1053-1058
4. Seidenari S., Pagnoni A., Di Nardo A., and Giannetti A. Echographic evaluation with image analysis of normal skin: Variations according to age and sex. Skin Pharmacol 7 (1994) 201-209
5. Sjostrom L., Smith U., Krotkiewski M., and Bjorntorp P. Cellularity in different regions of adipose tissue in young men and women. Metabolism 21 (1972) 1143-1153
6. Leveque J., Corcuff P., de Rigal J., and Agache P. In vivo studies of the evolution of physical properties of the human skin with age. Int J Dermatol 23 (1984) 322-329
7. Bolognia J. Aging skin. Am J Med 98 (1995) 99S-103S
8. Punnonen R. Effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand Suppl 21 (1972) 3-44
9. Korting H., Lukacs A., Vogt N., et al. Influence of the pH-value on the growth of Staphylococcus epidermidis, Staphylococcus aureus and Propionibacterium acnes in continuous culture. Zentralbl Hyg Umweltmed 193 (1992) 78-90
10. Mauro T., Holleran W., Grayson S., et al. Barrier recovery is impeded at neutral pH, independent of ionic effects: Implications for extracellular lipid processing [published correction appears in Arch Dermatol Res. 1998;290:405]. Arch Dermatol Res 290 (1998) 215-222
11. Sznitowska M., Janicki S., Williams A., et al. pH-induced modifications to stratum corneum lipids investigated using thermal, spectroscopic, and chromatographic techniques. J Pharm Sci 92 (2003) 173-179
12. Marples R. Sex, constancy, and skin bacteria. Arch Dermatol Res 272 (1982) 317-320
13. Cornbleet T. Pregnancy and apocrine gland diseases: Hidradenitis, Fox-Fordyce disease. AMA Arch Derm Syphilol 65 (1952) 12-19
14. Parra J., Paye M., and for the EEMCO Group. EEMCO guidance for the in vivo assessment of skin surface pH. Skin Pharmacol Appl Skin Physiol 16 (2003) 188-202
15. Yosipovitch G., Tur E., Cohen O., and Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care 16 (1993) 560-563
16. Wilhelm K., Cua A., and Maibach H. Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol 127 (1991) 1806-1809
17. Ohman H., and Vahlquist A. In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol 74 (1994) 375-379
18. Blank I. I. Measurement of pH on the skin surface. II. pH of the exposed surfaces of adults with no apparent skin lesions. J Invest Dermatol 2 (1939) 75-79
19. Jacobi U., Gautier J., Sterry W., and Lademann J. Genderrelated differences in the physiology of the stratum corneum. Dermatology 211 (2005) 312-317
20. Kim M., Patel R., Shinn A., et al. Evaluation of gender difference in skin type and pH. J Dermatol Sci 41 (2006) 153-156
21. Ehlers C., Ivens U., Moller M., et al. Females have lower skin surface pH than men. A study on the surface of gender, forearm site variation, right/left difference and time of the day on the skin surface pH. Skin Res Technol 7 (2001) 90-94
22. Korting H., Kober M., Mueller M., and Braun-Falco O. Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. Acta Derm Venereol 67 (1987) 41-47
23. Green J., Bishop P., Muir I., and Lomax R. Gender differences in sweat lactate. Eur J Appl Physiol 82 (2000) 230-235
24. Williams S., Davids M., Reuther T., et al. Gender difference of in vivo skin surface pH in the axilla and the effect of a standardized washing procedure with tap water. Skin Pharmacol Physiol 18 (2005) 247-252
25. Cua A., Wilhelm K., and Maibach H. Skin surface lipid and skin friction: Relation to age, sex and anatomical region. Skin Pharmacol 8 (1995) 246-251
26. Denda M., Koyama J., Hori J., et al. Age- and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res 285 (1993) 415-417
27. Lahita R. Gender and the immune system. J Gend Specif Med 3 (2000) 19-22
28. Jarefors S., Bennet L., You E., et al. Lyme borreliosis reinfection: Might it be explained by a gender difference in immune response?. Immunology 118 (2006) 224-232
29. Mosselman S., Polman J., and Dijkema R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392 (1996) 49-53
30. Mor G., Sapi E., Abrahams V., et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170 (2003) 114-122
31. Liu H., Loo K., Palaszynski K., et al. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol 171 (2003) 6936-6940
32. Giltay E., Fonk J., von Blomberg B., et al. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 85 (2000) 1648-1657
33. Struve J., Aronsson B., Frenning B., et al. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: A comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 24 (1992) 423-429
34. Whitacre C., Reingold S., and O'Looney P. A gender gap in autoimmunity. Science 283 (1999) 1277-1278
35. Beagley K., and Gockel C. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 38 (2003) 13-22
36. Cutolo M., Sulli A., Capellino S., et al. Sex hormones influence on the immune system: Basic and clinical aspects in autoimmunity. Lupus 13 (2004) 635-638
37. Cutolo M., Sulli A., Seriolo B., et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13 (1995) 217-226
38. Lahita R. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 11 (1999) 352-356
39. Seli E., and Arici A. Sex steroids and the immune system. Immunol Allergy Clin North Am 22 (2002) 407-433
40. Ackerman L. Sex hormones and the genesis of autoimmunity. Arch Dermatol 142 (2006) 371-376
41. Bynoe M., Grimaldi C., and Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 97 (2000) 2703-2708
42. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
43. Gartler S., and Goldman M. Biology of the X chromosome. Curr Opin Pediatr 13 (2001) 340-345
44. Ranke M., and Saenger P. Turner's syndrome. Lancet 358 (2001) 309-314
45. Banchereau J., and Steinman R. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
46. Katz S., Cooper K., Iijima M., and Tsuchida T. The role of Langerhans cells in antigen presentation. J Invest Dermatol 85 Suppl 1 (1985) 96s-98s
47. Wolff K., and Stingl G. The Langerhans cell. J Invest Dermatol 80 Suppl (1983) 17s-21s
48. Bergstresser P., Fletcher C., and Streilein J. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 74 (1980) 77-80
49. Streilein J., Lonsberry L., and Bergstresser P. Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 155 (1982) 863-871
50. Toews G., Bergstresser P., and Streilein J. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124 (1980) 445-453
51. Berglund J., Eitrem R., Ornstein K., et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333 (1995) 1319-1327
52. Orloski K., Hayes E., Campbell G., and Dennis D. Surveillance for Lyme disease-United States, 1992-1998. MMWR CDC Surveill Summ 49 (2000) 1-11
53. Bennet L., and Berglund J. Reinfection with Lyme borreliosis: A retrospective follow-up study in southern Sweden. Scand J Infect Dis 34 (2002) 183-186
54. Balleari E., Ghirlanda P., Garre S., et al. Genderrelated analysis of thrombopoietic cytokine pattern in patients with immune thrombocytopenic purpura. Ann N Y Acad Sci 876 (1999) 387-390
55. Vainchenker W., Debili N., Mouthon M., and Wendling F. Megakaryocytopoiesis: Cellular aspects and regulation. Crit Rev Oncol Hematol 20 (1995) 165-192
56. Deshpande R., Khalili H., Pergolizzi R., et al. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 38 (1997) 46-54
57. Sanchez-Guerrero J., Liang M., Karlson E., et al. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122 (1995) 430-433
58. Lord R., Bongiovanni B., and Bralley J. Estrogen metabolism and the diet-cancer connection: Rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 7 (2002) 112-129
59. Cutolo M. Estrogen metabolites: Increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31 (2004) 419-421
60. Jara-Quezada L., Graef A., and Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 18 (1991) 349-353
61. Lahita R. The importance of estrogens in systemic lupus erythernatosus. Clin Immunol Immunopathol 63 (1992) 17-18
62. Lavalle C., Loyo E., Paniagua R., et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 14 (1987) 268-272
63. Costner M., and Grau R. Update on connective tissue diseases in dermatology. Semin Cutan Med Surg 25 (2006) 207-220
64. Medsger Jr. T., and Masi A. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74 (1971) 714-721
65. Steen V., Oddis C., Conte C., et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 40 (1997) 441-445
66. Invernizzi P., Miozzo M., Selmi C., et al. X chromosome monosomy: A common mechanism for autoimmune diseases. J Immunol 175 (2005) 575-578
67. Kettaneh A., Al Moufti O., Tiev K., et al. Occupational exposure to solvents and genderrelated risk of systemic sclerosis: A metaanalysis of case-control studies. J Rheumatol 34 (2007) 97-103
68. Simeon C., Castro-Guardiola A., Fonollosa V., et al. Systemic sclerosis in men: Clinical and immunological differences. Br J Rheumatol 35 (1996) 910-911
69. Scussel-Lonzetti L., Joyal F., Raynauld J., et al. Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81 (2002) 154-167
70. Peters-Golden M., Wise R., Hochberg M., et al. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 77 (1984) 1027-1034
71. Wynn J., Fineberg N., Matzer L., et al. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 110 (1985) 123-127
72. Altman R., Medsger Jr. T., Bloch D., and Michel B. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34 (1991) 403-413
73. Simeon C., Fonollosa V., Armadans L., et al. Systemic sclerosis subsets according to analysis of survival and disability prognostic factors. Abstract. Br J Rheumatol 33 Suppl 1 (1994) 59
74. Harris Jr. E. Rheumatoid arthritis. Pathophysiology and implications for therapy [published correction appears in N Engl J Med. 1990;323:996]. N Engl J Med 322 (1990) 1277-1289
75. Buckwalter J., and Lappin D. The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop Relat Res 372 (2000) 159-168
76. Kvien T., Glennas A., Knudsrod O., et al. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 26 (1997) 412-418
77. Kvien T., Uhlig T., Odegard S., and Heiberg M. Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann N Y Acad Sci 1069 (2006) 212-222
78. Uhlig T., and Kvien T. Is rheumatoid arthritis disappearing?. Ann Rheum Dis 64 (2005) 7-10
79. Kaipiainen-Seppanen O., Aho K., Isomaki H., and Laakso M. Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis 55 (1996) 608-611
80. Doran M., Pond G., Crowson C., et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46 (2002) 625-631
81. Doran M., Crowson C., O'Fallon W., and Gabriel S. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: A population based study. J Rheumatol 31 (2004) 207-213
82. Krishnan E., Sokka T., and Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 5 (2003) R158-R162
83. Symmons D., Barrett E., Bankhead C., et al. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br J Rheumatol 33 (1994) 735-739
84. Uhlig T., Kvien T., Glennas A., et al. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 25 (1998) 1078-1084
85. Gossec L., Baro-Riba J., Bozonnat M., et al. Influence of sex on disease severity in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 1448-1451
86. Weyand C., Schmidt D., Wagner U., and Goronzy J. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 41 (1998) 817-822
87. Thornton M., Taylor A., Mulligan K., et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 12 (2003) 181-190
88. Pelletier G., and Ren L. Localization of sex steroid receptors in human skin. Histol Histopathol 19 (2004) 629-636
89. Hamilton J. Male hormone stimulation is a pre-requisite and an incitant in common baldness. Am J Anat 71 (1942) 451-480
90. Hamilton J. Patterned loss of hair in man: Types and incidence. Ann N Y Acad Sci 53 (1951) 708-728
91. Griffin J., and Wilson J. The resistance syndromes: 5α-Reductase deficiency, testicular feminisation and related disorders. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic Basis of Inherited Disease. 6th ed (1989), McGraw Hill, New York, NY 1919-1944
92. Gustafsson J. An update on estrogen receptors. Semin Perinatol 24 (2000) 66-69
93. Wallace M., and Smoller B. Estrogen and progesterone receptors in androgenic alopecia versus alopecia areata. Am J Dermatopathol 20 (1998) 160-163
94. West N., Carlisle K., and Brenner R. Progesterone treatment suppresses estrogen receptor in the sex skin of Macaca nemestrina. J Steroid Biochem 35 (1990) 481-485
95. Olsen E. Female pattern hair loss. J Am Acad Dermatol 45 Suppl 3 (2001) S70-S80
96. Price V. Androgenetic alopecia in women. J Investig Dermatol Syrup Proc 8 (2003) 24-27
97. Rosenfield R. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Syrup Proc 10 (2005) 205-208
98. Ohnemus U., Uenalan M., Conrad F., et al. Hair cycle control by estrogens: Catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling. Endocrinology 146 (2005) 1214-1225
99. Schumacher-Stock U. Estrogen treatment of hair diseases. In: Orfanos C., Montagna W., and Stuttgen G. (Eds). Hair Research (1981), Springer-Verlag, Berlin, Germany 318-321
100. Conrad F., Ohnemus U., Bodo E., et al. Substantial sex-dependent differences in the response of human scalp hair follicles to estrogen stimulation in vitro advocate gender-tailored management of female versus male pattern balding. J Investig Dermatol Syrup Proc 10 (2005) 243-246
101. Toyoda M., and Morohashi M. Pathogenesis of acne. Med Electron Microsc 34 (2001) 29-40
102. Zouboulis C., Eady A., Philpott M., et al. What is the pathogenesis of acne?. Exp Dermatol 14 (2005) 143-152
103. Pochi P., Strauss J., and Downing D. Age-related changes in sebaceous gland activity. J Invest Dermatol 73 (1979) 108-111
104. Strauss J., Kligman A., and Pochi P. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 39 (1962) 139-155
105. Guy R., Ridden C., and Kealey T. The improved organ maintenance of the human sebaceous gland: Modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol 106 (1996) 454-460
106. Gollnick H., Cunliffe W., Berson D., et al., for the Global Alliance to Improve Outcomes in Ache. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49 Suppl 1 (2003) S1-S37
107. James W. Clinical practice. Acne. N Engl J Med 352 (2005) 1463-1472
108. Thiboutot D., Harris G., Iles V., et al. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 105 (1995) 209-214
109. Thiboutot D., Knaggs H., Gilliland K., and Lin G. Activity of 5-alpha-reductase and 17-beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 196 (1998) 38-42
110. Leyden J., McGinley K., Mills O., and Kligman A. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 65 (1975) 382-384
111. Makrantonaki E., and Zouboulis C. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 156 (2007) 428-432
112. Azzi L., El-Alfy M., and Labrie F. Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen alpha receptors in mouse sebaceous glands. Br J Dermatol 154 (2006) 21-27
113. Zouboulis C., Chen W., Thornton M., et al. Sexual hormones in human skin. Horm Metab Res 39 (2007) 85-95
114. Ganceviciene R., Graziene V., Bohm M., and Zouboulis C. Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 16 (2007) 547-552
115. Cunliffe W., Shuster S., and Smith A. The effect of topical cyproterone acetate on sebum secretion in patients with acne. Br J Dermatol 81 (1969) 200-201
116. Pochi P., and Strauss J. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol 62 (1974) 191-201
117. Illi S., von Mutius E., Lau S., et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113 (2004) 925-931
118. Kerkhof M., Koopman L., van Strien R., et al., for the PIAMA Study Group. Risk factors for atopic dermatitis in infants at high risk of allergy: The PIAMA study. Clin Exp Allergy 33 (2003) 1336-1341
119. Wadonda-Kabondo N., Sterne J., Golding J., et al., for the ALSPAC Study Team. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 149 (2003) 1023-1028
120. Mohrenschlager M., Schafer T., Huss-Marp J., et al. The course of eczema in children aged 5-7 years and its relation to atopy: Differences between boys and girls. Br J Dermatol 154 (2005) 505-513
121. Moore M., Rifas-Shiman S., Rich-Edwards J., et al. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics 113 (2004) 468-474
122. Butland B., Strachan D., Lewis S., et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 315 (1997) 717-721
123. Mortz C., Lauritsen J., Bindslev-Jensen C., Andersen K., and for the Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. Br J Dermatol 144 (2001) 523-532
124. Weiland S., von Mutius E., Hirsch T., et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. Eur Respir J 14 (1999) 862-870
125. Tay Y., Kong K., Khoo L., et al. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 146 (2002) 101-106
126. Seidenari S., Giusti G., Bertoni L., et al. Thickness and echogenicity of the skin in children as assessed by 20-MHz ultrasound. Dermatology 201 (2000) 218-222
127. Schafer T., Kramer U., Vieluf D., et al. The excess of atopic eczema in East Germany is related to the intrinsic type. Br J Dermatol 143 (2000) 992-998
128. Hanley K., Rassner U., Jiang Y., et al. Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97 (1996) 2576-2584
129. Fimmel S., and Zouboulis C. Influence of physiological androgen levels on wound healing and immune status in men. Aging Male 8 (2005) 166-174
130. Gilliver S., Wu F., and Ashcroft G. Regulatory roles of androgens in cutaneous wound healing. Thromb Haemost 90 (2003) 978-985
131. Padgett D., and Loria R. Endocrine regulation of murine macrophage function: Effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol 84 (1998) 61-68
132. Graft R., Lappe M., and Snell G. The influence of the gonads and adrenal glands on the immune response to skin grafts. Transplantation 7 (1969) 105-111
133. Koyama Y., Nagao S., Ohashi K., et al. Sex differences in the densities of epidermal Langerhans cells of the mouse. J Invest Dermatol 88 (1987) 541-544
134. Castro J. Immunological effects of orchidectomy. Br J Urol 47 (1975) 89-95
135. Berman B., Chen V., France D., et al. Anatomical mapping of epidermal Langerhans cell densities in adults. Br J Dermatol 109 (1983) 553-558
136. Chen H., Yuan J., Wang Y., and Silvers W. Distribution of ATPase-positive Langerhans cells in normal adult human skin. Br J Dermatol 113 (1985) 707-711
137. Wolff K., and Winkelmann R. Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol 48 (1967) 504-513
138. Gilchrest B., Murphy G., and Soter N. Effect of chronologic aging and ultraviolet irradiation on Langerhans cells in human epidermis. J Invest Dermatol 79 (1982) 85-88
139. Koyama Y., Nagao S., Ohashi K., et al. Effect of systemic and topical application of testosterone propionate on the density of epidermal Langerhans cells in the mouse. J Invest Dermatol 92 (1989) 86-90
140. Muramatsu K., Kurokawa Y., Ihara K., et al. Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation. J Surg Res 115 (2003) 106-112
141. Simpson E., Chandler P., McLaren A., et al. Mapping the H-Y gene. Development 101 Suppl (1987) 157-161
142. Eichwald E., and Davidson N. Male-specific graft rejection of mouse tumours and the Y chromosome. Folia Biol (Praha) 14 (1968) 89-92
143. Eichwald E., and Silmser C. H-Y and serendipity. Hum Genet 58 (1981) 6-8
144. Ashcroft G., and Mills S. Androgen receptormediated inhibition of cutaneous wound healing. J Clin Invest 110 (2002) 615-624
145. Ashcroft G., Greenwell-Wild T., Horan M., et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 155 (1999) 1137-1146
146. Herrick S., Ashcroft G., Ireland G., et al. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. Lab Invest 77 (1997) 281-288
147. Ashcroft G., Horan M., and Ferguson M. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 78 (1998) 47-58
148. Albers M., de Gast-Bakker D., van Dam N., et al. Male sex predisposes the newborn surgical patient to parenteral nutrition-associated cholestasis and to sepsis. Arch Surg 137 (2002) 789-793
149. George R., McGwin Jr. G., Metzger J., et al. The association between gender and mortality among trauma patients as modified by age. J Trauma 54 (2003) 464-471
150. Majetschak M., Christensen B., Obertacke U., et al. Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: Relationship to the development of severe sepsis. J Trauma 48 (2000) 832-839 discussion 839-840
151. Oberholzer A., Keel M., Zellweger R., et al. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 48 (2000) 932-937
152. Offner P., Moore E., and Biffl W. Male gender is a risk factor for major infections after surgery. Arch Surg 134 (1999) 935-938 discussion 938-940
153. Wichmann M., Inthorn D., Andress H., and Schildberg F. Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med 26 (2000) 167-172
154. Wichmann M., Zellweger R., DeMaso C., et al. Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 8 (1996) 853-863
155. Schroder J., Kahlke V., Staubach K., et al. Gender differences in human sepsis. Arch Surg 133 (1998) 1200-1205
156. Christeff N., Carli A., Benassayag C., et al. Relationship between changes in serum estrone levels and outcome in human males with septic shock. Circ Shock 36 (1992) 249-255
157. Fourrier F., Jallot A., Leclerc L., et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock 43 (1994) 171-178
158. Lephart E., Baxter C., and Parker Jr. C. Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 64 (1987) 842-848
159. Messingham K., Shirazi M., Duffner L., et al. Testosterone receptor blockade restores cellular immunity in male mice after burn injury. J Endocrinol 169 (2001) 299-308
160. Sharma A., Bosmann H., Motew S., et al. Steroid hormone alterations following induction of chronic intraperitoneal sepsis in male rats. Shock 6 (1996) 150-154
161. Nitsch S., Wittmann F., Angele P., et al. Physiological levels of 5 alpha-dihydrotestosterone depress wound immune function and impair wound healing following trauma-hemorrhage. Arch Surg 139 (2004) 157-163
162. Ashcroft G., Dodsworth J., van Boxtel E., et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3 (1997) 1209-1215
163. Cotsarelis G. Hair follicle stem cells: Their location and roles. In: Camacho F., Randall V., and Price V. (Eds). Hair Biology and Its Disorders: Biology, Pathology and Management (2000), Martin Dunitz, London, UK 39-47
164. Lupulescu A. Hormonal regulation of epidermal tumor development. J Invest Dermatol 77 (1981) 186-195
165. Ishida H., Wada K., Masuda T., et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci 98 (2007) 636-643
166. Jee S., Lee S., Chiu H., et al. Effects of estrogen and estrogen receptor in normal human melanocytes. Biochem Biophys Res Commun 199 (1994) 1407-1412
167. Duncan L., Travers R., Koerner F., et al. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: Absence of immunohistochemically detectable hormone receptors. Hum Pathol 25 (1994) 36-41
168. Schmidt A., Nanney L., Boyd A., et al. Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol 15 (2006) 971-980
169. American Cancer Society. Cancer Facts and Figures 2002. http://www.cancer.org/downloads/STT/CancerFactsFigures2002TM.pdf
170. Clark Jr. W., Elder D., Guerry IV D., et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81 (1989) 1893-1904
171. Garbe C., Buttner P., Bertz J., et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75 (1995) 2484-2491
172. Karakousis C., Emrich L., and Rao U. Tumor thickness and prognosis in clinical stage I malignant melanoma. Cancer 64 (1989) 1432-1436
173. Shaw H., McGovern V., Milton G., et al. Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 45 (1980) 1604-1608
174. Balch C., Soong S., Gershenwald J., et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
175. Carlson G., Murray D., Hestley A., et al. Sentinel lymph node mapping for thick (>or=4-mm) melanoma: Should we be doing it?. Ann Surg Oncol 10 (2003) 408-415
176. Howe H., Wingo P., Thun M., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93 (2001) 824-842
177. Ries L., Wingo P., Miller D., et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88 (2000) 2398-2424
178. Scoggins C., Ross M., Reintgen D., et al., for the Sunbelt Melanoma Trial. Gender-related differences in outcome for melanoma patients. Ann Surg 243 (2006) 693-698 discussion 698-700
179. Chao C., Martin II R., Ross M., et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 11 (2004) 259-264
180. Chao C., Wong S., Ross M., et al., for the Sunbelt Melanoma Trial Group. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 184 (2002) 520-524 discussion 525
181. Clary B., Brady M., Lewis J., and Coit D. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233 (2001) 250-258
182. Essner R., Conforti A., Kelley M., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6 (1999) 442-449
183. Gershenwald J., Thompson W., Mansfield P., et al. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 (1999) 976-983
184. McMasters K., Noyes R., Reintgen D., et al., for the Sunbelt Melanoma Trial. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 86 (2004) 212-223
185. McMasters K., Wong S., Edwards M., et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 130 (2001) 151-156
186. Lambe M., Thorn M., Sparen P., et al. Malignant melanoma: Reduced risk associated with early childbearing and multiparity. Melanoma Res 6 (1996) 147-153
187. Karagas M., Zens M., Stukel T., et al. Pregnancy history and incidence of melanoma in women: A pooled analysis. Cancer Causes Control 17 (2006) 11-19
188. Katz V., Farmer R., and Dotters D. Focus on primary care: From nevus to neoplasm: Myths of melanoma in pregnancy. Obstet Gynecol Surv 57 (2002) 112-119
189. Bastiaens M., Hoefnagel J., Bruijn J., et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110 (1998) 880-884
190. Raasch B., Buettner P., and Garbe C. Basal cell carcinoma: Histological classification and body-site distribution. Br J Dermatol 155 (2006) 401-407
191. Scrivener Y., Grosshans E., and Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147 (2002) 41-47
192. Katalinic A., Kunze U., and Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: Incidence, clinical subtypes, turnout stages and localization (epidemiology of skin cancer). Br J Dermatol 149 (2003) 1200-1206
193. Karagas M., Greenberg E., Spencer S., et al., for the New Hampshire Skin Cancer Study Group. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 81 (1999) 555-559
194. Buettner P., and Raasch B. Incidence rates of skin cancer in Townsville, Australia [published correction appears in Int J Cancer. 2001;93:302-303]. Int J Cancer 78 (1998) 587-593
195. Cancer Incidence in Sweden 1998 (2000), Center for Epidemiology, Stockholm, Sweden
196. Pearl D., and Scott E. The anatomical distribution of skin cancers. Int J Epidemiol 15 (1986) 502-506
197. Rowe D., Gallagher R., Warshawski L., and Carruthers A. Females vastly outnumber males in basal cell carcinoma of the upper lip. A peculiar subset of high risk young females is described. J Dermatol Surg Oncol 20 (1994) 754-756
198. Miller S., Sun T., and Lavker R. Hair follicles, stem cells, and skin cancer. J Invest Dermatol 100 (1993) 288S-294S
199. Boxman I., Berkhout R., Mulder L., et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 108 (1997) 712-715
200. Gupta M., and Gupta A. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 34 (1995) 700-703
201. Schmid-Ott G., Jaeger B., Kuensebeck H., et al. Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints.". Dermatology 193 (1996) 304-310
202. Jemec G., and Serup J. Scaling, dry skin and gender. A bioengineering study of dry skin. Acta Derm Venereol Suppl (Stockh) 177 (1992) 26-28